Antibodies specific to human Nectin-2
US-12545727-B2 · Feb 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd — Cross-Sectional Technologies
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd holds 92 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 92 |
| Recent patents in slice | 15 |
| First year | 2017 |
| Last year | 2026 |
Representative patents
Notable publications linking Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd to Cross-Sectional Technologies.
Formulations for preventing mosquito bites
US-2025345261-A1 · Nov 13, 2025 · US
Perovskite compositions and uses thereof in photovoltaic devices
US-2025287768-A1 · Sep 11, 2025 · US
A process for treating sludge
US-2025206648-A1 · Jun 26, 2025 · US
Compositions and methods for management of whitefly
US-2025027105-A1 · Jan 23, 2025 · US
Recent filings
Latest patents from Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd in Cross-Sectional Technologies.
Antibodies specific to human Nectin-2
US-12545727-B2 · Feb 10, 2026 · US
Formulations for preventing mosquito bites
US-2025345261-A1 · Nov 13, 2025 · US
Perovskite compositions and uses thereof in photovoltaic devices
US-2025287768-A1 · Sep 11, 2025 · US
A process for treating sludge
US-2025206648-A1 · Jun 26, 2025 · US
Compositions and methods for management of whitefly
US-2025027105-A1 · Jan 23, 2025 · US
Related pages
Navigate to parent entity pages.